The Use of Pomalidomide in the Treatment of Relapsed/Refractory Multiple Myeloma in Patients with Renal Failure

The present review includes data on efficacy and safety of pomalidomide, an immunomodulating 3rd generation drug used for treatment of relapsed and refractory multiple myeloma patients with renal failure. The results of multicenter randomized trials proved similar efficacy and comparable safety prof...

Full description

Bibliographic Details
Published in:Клиническая онкогематология
Main Authors: IG Rekhtina, MV Nareiko, LP Mendeleeva
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2018-10-01
Subjects:
pomalidomide
multiple myeloma
renal failure
Online Access:http://bloodjournal.ru/wp-content/uploads/2018/09/1-1.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2018/09/1-1.pdf

Similar Items